down arrow

Suraksha Diagno.

  • Market Cap: Small Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE877V01027
  • NSEID: SURAKSHA
  • BSEID: 544293
INR
276.90
-1.35 (-0.49%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 29.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Suraksha Diagnostic Ltd stock-summary
stock-summary
Suraksha Diagnostic Ltd
Small Cap
Hospital & Healthcare Services
Suraksha Diagnostic Limited was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata. Subsequently, Company was converted into a public limited company and the name of Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ritu Mittal (19.99%)

Highest Public shareholder

OrbiMed Asia II Mauritius Limited (33.35%)

Individual Investors Holdings

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
60 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 1,442 Cr (Small Cap)

stock-summary
P/E

58.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.24

stock-summary
Return on Equity

13.80%

stock-summary
Price to Book

8.01